These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Acute bacterial rhinosinusitis in adults: part II. Treatment. Scheid DC; Hamm RM Am Fam Physician; 2004 Nov; 70(9):1697-704. PubMed ID: 15554487 [TBL] [Abstract][Full Text] [Related]
43. Surfactant protein A and D in chronic rhinosinusitis with nasal polyposis and corticosteroid response. Salman S; Akpinar ME; Yigit O; Gormus U Am J Rhinol Allergy; 2012; 26(2):e76-80. PubMed ID: 22487281 [TBL] [Abstract][Full Text] [Related]
44. Pediatric atrophic rhinosinusitis: what can we do? Magalhães C; Viana M; Alves V; Nakamura R; Duarte D Int J Pediatr Otorhinolaryngol; 2015 May; 79(5):763-5. PubMed ID: 25799383 [TBL] [Abstract][Full Text] [Related]
45. Staphylococcus aureus in nasal lavage and biopsy of patients with chronic rhinosinusitis. Niederfuhr A; Kirsche H; Deutschle T; Poppert S; Riechelmann H; Wellinghausen N Allergy; 2008 Oct; 63(10):1359-67. PubMed ID: 18782116 [TBL] [Abstract][Full Text] [Related]
46. The effect of corticosteroids in the treatment of experimental sinusitis. Cable BB; Wassmuth Z; Mann EA; Hommer D; Connely G; Klem C; Quance-Fitch FJ; Bolger WE Am J Rhinol; 2000; 14(4):217-22. PubMed ID: 10979493 [TBL] [Abstract][Full Text] [Related]
47. Sinus Microanatomy and Microbiota in a Rabbit Model of Rhinosinusitis. Cho DY; Mackey C; Van Der Pol WJ; Skinner D; Morrow CD; Schoeb TR; Rowe SM; Swords WE; Tearney GJ; Woodworth BA Front Cell Infect Microbiol; 2017; 7():540. PubMed ID: 29376039 [No Abstract] [Full Text] [Related]
48. In vitro activity of mupirocin on clinical isolates of Staphylococcus aureus and its potential implications in chronic rhinosinusitis. Ha KR; Psaltis AJ; Butcher AR; Wormald PJ; Tan LW Laryngoscope; 2008 Mar; 118(3):535-40. PubMed ID: 18090864 [TBL] [Abstract][Full Text] [Related]
49. Efficacy of Primary Collagen Cross-Linking with Photoactivated Chromophore (PACK-CXL) for the Treatment of Staphylococcus aureus-Induced Corneal Ulcers. Tal K; Gal-Or O; Pillar S; Zahavi A; Rock O; Bahar I Cornea; 2015 Oct; 34(10):1281-6. PubMed ID: 26252742 [TBL] [Abstract][Full Text] [Related]
51. Developing a mouse model of acute bacterial rhinosinusitis. Jin M; Gu Z; Bian Z; Yang J; Cao Z; Yu X; Guo G Eur Arch Otorhinolaryngol; 2011 Jun; 268(6):857-61. PubMed ID: 21267587 [TBL] [Abstract][Full Text] [Related]
52. Bactrim reduces the inflammatory response in a murine model of acute rhinosinusitis. Won YS; Brichta A; Baroody F; Boonlayangoor S; Naclerio R Rhinology; 2000 Jun; 38(2):68-71. PubMed ID: 10953844 [TBL] [Abstract][Full Text] [Related]
53. Antibiotics for acute rhinosinusitis. Kaiser L; Hirschel B Arch Intern Med; 2004 Mar; 164(5):568; author reply 570. PubMed ID: 15006837 [No Abstract] [Full Text] [Related]
54. The successful treatment of gatifloxacin-resistant Staphylococcus aureus keratitis with Zymar (gatifloxacin 0.3%) in a NZW rabbit model. Romanowski EG; Mah FS; Yates KA; Kowalski RP; Gordon YJ Am J Ophthalmol; 2005 May; 139(5):867-77. PubMed ID: 15860293 [TBL] [Abstract][Full Text] [Related]
55. Comparison of topical 0.3% ofloxacin with fortified tobramycin plus cefazolin in the treatment of bacterial keratitis. Panda A; Ahuja R; Sastry SS Eye (Lond); 1999 Dec; 13 ( Pt 6)():744-7. PubMed ID: 10707137 [TBL] [Abstract][Full Text] [Related]
56. Prevalence of biofilm-forming bacteria in chronic rhinosinusitis. Prince AA; Steiger JD; Khalid AN; Dogrhamji L; Reger C; Eau Claire S; Chiu AG; Kennedy DW; Palmer JN; Cohen NA Am J Rhinol; 2008; 22(3):239-45. PubMed ID: 18588755 [TBL] [Abstract][Full Text] [Related]
57. Staphylococcus aureus small colony variants: Prevalence in chronic rhinosinusitis and induction by antibiotics. Zhang G; Zhao Y; Hayes AJ; Psaltis AJ; Wormald PJ; Vreugde S Allergy; 2018 Dec; 73(12):2403-2405. PubMed ID: 30055001 [No Abstract] [Full Text] [Related]